Five Ways R.F.K. Jr. Could Undermine Lifesaving Childhood Vaccines

Published On Nov 19, 2024, 5:04 AM

Robert F. Kennedy Jr., known for his criticism of vaccines, is potentially set to become the U.S. Secretary of Health and Human Services (H.H.S.). If confirmed, he may impact immunization policies and vaccine research in the country. Despite assurances that he will not ban vaccines, his influence could lead to reduced vaccination rates and a delay in vaccine development. This raises concerns about public health, as past vaccination programs have significantly decreased disease cases and hospitalizations.

Read full article

Stock Forecasts

MRNAView MRNA chart on TradingView

Negative

Investors should be wary of companies that rely heavily on vaccine sales, as shifts in public health policy under Kennedy could lead to lower vaccination rates. This could negatively impact revenue for vaccine manufacturers and related biotech firms.

IBBView IBB chart on TradingView

Neutral

ETFs focused on healthcare and biotechnology might see volatility as public sentiment and vaccination rates could change with Kennedy's policies. However, diversified healthcare ETFs may remain stable.

Related News

Stock market today: Dow, S&P 500, Nasdaq sink as post-election rally fades, Fed prompts rate-cut rethink

Nov 15, 2024, 1:15 PM

Wall Street is absorbing a jump in retail sales and Jerome Powell's hawkish comments as Trump-fueled optimism starts to wear off.

SPY
PLTR
PFE
MRNA

Stock market today: Dow, S&P 500, Nasdaq tumble as traders trim rate-cut bets

Nov 15, 2024, 11:04 AM

Wall Street is absorbing a jump in retail sales and Jerome Powell's hawkish comments as Trump-fueled optimism starts to wear off.

SPY
MRNA

Health stocks hit after Trump taps RFK for top regulator post

Nov 15, 2024, 10:52 AM

Investors are "spooked" by plan to name a vaccine-sceptic as US health secretary, analysts say.

PFE
MRNA
AZN
XLV